Page 61 - MemoriaCIBER-2018ENG
P. 61
   Scientific Director’s Presentation
Jordi Bruix Tudó
In 2018 the constant approach of high-level scientific activity continued with a large number of publications in journals with great impact.
In many cases the results obtained had a direct impact on patients’ health care. This translation displays the consolidation of the CIBEREHD as
a forceful research structure with significant benefit for the community in terms of public health. All of this was done in spite of the budget difficulties and the limitations for hiring new researchers consolidating them.
The annual report sets forth the most relevant results in the different Programmes of the CIBEREHD and means one can appreciate the gradual increase in cooperative studies with international impact in all the programmes both in Spain and abroad. One interesting point is that international collaboration work is often led by researchers from the CIBEREHD, that translates in international recognition.
Research has been relevant in basic aspects but, as has been stressed, this was particularly significant in translation to patients affected by liver and digestive diseases. Different clinical
practice guides based on scientific evidence have been published as well as consensus documents in which the criteria and methods to be used in both basic and clinical research are defined.
Lastly, the CIBEREHD is backed by shared platforms which have played a relevant role on both the training level and as regards furthering extremely competitive research.
Scientific Management and the Management Committee as a whole continue to implement the four-year action plan, but a redesigning process is under way to tackle the evolutionary changes that are instrumental for the further expansion and success of the scientific activity. An increase in generation renewal and gender balancing has been attained on all levels. We continue to identify young researchers with scientific career ambitions in order to guarantee maintenance of research culture in Biomedicine. In this respect, three new high-level teams led by female researchers joined us in 2018, and their contribution has been significant right from the start.
  61
 CIBEREHD | ANNUAL REPORT 2018























































































   59   60   61   62   63